Aviron nasal spray flu vaccine PLA filing in children and adults planned for mid-1998.
Executive Summary
AVIRON NASAL SPRAY FLU VACCINE PLA FILING PLANNED FOR MID-1998 based on data from a Phase III trial in children and an upcoming study in healthy adults. Mountain View, Calif.-based Aviron and the National Institute of Allergy and Infectious Diseases, which co-funded the pediatric trial, announced initial results of the study with the live, attenuated cold-adapted influenza vaccine on July 14.